Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haverkort

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Maturitas|December 6, 2025
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancerFamke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2025
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerJohannes Knoth, Remi A Nout, Richard Pötter, et al.
The Lancet. Oncology|May 3, 2024
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trialsFamke C Wakkerman, Jiqing Wu, Hein Putter, et al.
Pediatric Research|September 27, 2024
Post-COVID-19 condition in children: epidemiological evidence stratified by acute disease severityCoen R Lap, Caroline L H Brackel, Angelique M A M Winkel, et al.
The Lancet. Oncology|December 25, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2026
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Physical Review Letters|April 11, 2026
Improved Limit on the Effective Electron Neutrino Mass with the ECHo-1k ExperimentF Adam, F Ahrens, L E Ardila Perez, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.
The Lancet. Oncology|February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort studyTimo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Maturitas|December 6, 2025
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancerFamke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2025
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical CancerJohannes Knoth, Remi A Nout, Richard Pötter, et al.
The Lancet. Oncology|May 3, 2024
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trialsFamke C Wakkerman, Jiqing Wu, Hein Putter, et al.
Pediatric Research|September 27, 2024
Post-COVID-19 condition in children: epidemiological evidence stratified by acute disease severityCoen R Lap, Caroline L H Brackel, Angelique M A M Winkel, et al.
The Lancet. Oncology|December 25, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2026
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Physical Review Letters|April 11, 2026
Improved Limit on the Effective Electron Neutrino Mass with the ECHo-1k ExperimentF Adam, F Ahrens, L E Ardila Perez, et al.
Pageof 23